Latest Advances in mHSPC: An Update From Berlin 2025

Keeping Current
20/11/2025 20 min
Latest Advances in mHSPC: An Update From Berlin 2025

Listen "Latest Advances in mHSPC: An Update From Berlin 2025"

Descargar episodio Ver en sitio original

Episode Synopsis

Does the year 2025 mark a true, tangible shift toward biomarker-driven precision medicine for metastatic hormone-sensitive prostate cancer (mHSPC)? Credit available for this activity expires: 11/18/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/latest-advances-mhspc-update-berlin-2025-2025a1000vlk?ecd=bdc_podcast_libsyn_mscpedu

More episodes of the podcast Keeping Current

How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer? 05/12/2025
Staying Ahead of the First Event: Evaluating the Evidence for Early LDL-C Lowering 04/12/2025
Optimizing Outcomes for Patients With IgAN: Novel B-Cell Targeted Therapies and the Changing Treatment Paradigm 02/12/2025
Advances in the Pharmacologic Management of Obesity: An Expert Digest of the Latest Data 27/11/2025
Breaking the Silence: Tackling Liver Fibrosis in MASH: Who to Treat With Novel Therapies 25/11/2025
Coexisting Comorbidities: Advancing Holistic Care in COPD 24/11/2025
Novel Biological Approaches for Enhanced Obesity and Diabetes Management – What's Next? 24/11/2025
Conference Insights: Breaking Developments in ALK-Positive NSCLC and ES-SCLC 20/11/2025
Charting the Course for Metastatic Breast Cancer Care: Optimizing First-Line Treatment and Beyond 17/11/2025
Paving the Way for Success in Integrating Biosimilars Into Multiple Sclerosis Care: Optimizing Communication 17/11/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA